DOXIPROCT ong tb 30 g

7680389320123 CH-38932 C05AD01 02.09.1.
DOXIPROCT ong tb 30 g
DOXIPROCT ong tb 30 g
DOXIPROCT ong tb 30 g
1 / 3
google

Details

Product number
3893201
CPT
-
Packaging group
30
Unit
g
Composition
calcii dobesilas monohydricus 40 mg, lidocaini hydrochloridum monohydricum 20 mg, polysorbatum 80, E 310, E 320 0.15 mg, acidum citricum, alcohol cetylicus 60 mg, macrogolum 300, macrogolum 1500, macrogolum 4000, propylenglycolum 310 mg, ad unguentum pro 1 g.

Articles (1)

Doxiproct, pommade rectale
pommade rectale
30
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
02/06/2025
Patient information leaflet
Français
02/06/2025
Patient information leaflet
Italien
02/06/2025
Professional SmPC
Allemand
02/06/2025
Professional SmPC
Français
02/06/2025
Professional SmPC
Italien
02/06/2025

Detailed composition

Substance Quantity Type Category
(N/A)
40.0 MG Substance Wirkstoff (Principe actif)
(N/A)
20.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance ANTOX
(N/A)
0.15 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
60.0 MG Substance HBESI
(N/A)
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
310.0 MG Substance HBESI

Authorization holder

OM Pharma SA

1217 Meyrin

Authorization information

Swissmedic authorization number
38932
Drug name
Doxiproct, pommade rectale
Galenic form
REKS
ATC Code
C05AD01
Authorization status
Z
Dispensation category
D
First authorization
02/04/1975
Authorization expiration date
31/12/9999
IT number
02.09.1.
Domain
Human medicine

Packaging details

Description (FR)
DOXIPROCT ong tb 30 g
Description (DE)
DOXIPROCT Salbe Tb 30 g
Market launch
02/04/1975
Narcotic (BTM)
No